Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining Colonoscopy With Fecal Immunochemical Test Can Improve Current Familial Colorectal Cancer Colonoscopy Surveillance: A Modelling Study.
van Wifferen F, Greuter MJE, van Leerdam ME, Spanier MBW, Dekker E, Vasen HFA, Lansdorp-Vogelaar I, Canfell K, Meijer GA, Bisseling TM, Hoogerbrugge N, Coupé VMH. van Wifferen F, et al. Among authors: coupe vmh. Gastroenterology. 2025 Jan;168(1):136-149. doi: 10.1053/j.gastro.2024.08.025. Epub 2024 Aug 28. Gastroenterology. 2025. PMID: 39214503 Free article.
Colonoscopy-controlled intra-individual comparisons to screen relevant neoplasia: faecal immunochemical test vs. guaiac-based faecal occult blood test.
Oort FA, Terhaar Sive Droste JS, Van Der Hulst RW, Van Heukelem HA, Loffeld RJ, Wesdorp IC, Van Wanrooij RL, De Baaij L, Mutsaers ER, van der Reijt S, Coupe VM, Berkhof J, Bouman AA, Meijer GA, Mulder CJ. Oort FA, et al. Aliment Pharmacol Ther. 2010 Feb 1;31(3):432-9. doi: 10.1111/j.1365-2036.2009.04184.x. Epub 2009 Oct 29. Aliment Pharmacol Ther. 2010. PMID: 19878150
Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.
Terhaar sive Droste JS, Oort FA, van der Hulst RW, van Heukelem HA, Loffeld RJ, van Turenhout ST, Ben Larbi I, Kanis SL, Neerincx M, Räkers M, Coupé VM, Bouman AA, Meijer GA, Mulder CJ. Terhaar sive Droste JS, et al. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):272-80. doi: 10.1158/1055-9965.EPI-10-0848. Epub 2010 Dec 6. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21135261
Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study.
Oort FA, van Turenhout ST, Coupé VM, van der Hulst RW, Wesdorp EI, Terhaar sive Droste JS, Larbi IB, Kanis SL, van Hengel E, Bouman AA, Meijer GA, Mulder CJ. Oort FA, et al. BMC Cancer. 2011 Oct 10;11:434. doi: 10.1186/1471-2407-11-434. BMC Cancer. 2011. PMID: 21985604 Free PMC article.
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ, Oort FA, Neerincx M, Khalid-de Bakker CA, Terhaar sive Droste JS, Melotte V, Jonkers DM, Masclee AA, Mongera S, Grooteclaes M, Louwagie J, van Criekinge W, Coupé VM, Mulder CJ, van Engeland M, Carvalho B, Meijer GA. Bosch LJ, et al. Cancer Prev Res (Phila). 2012 Mar;5(3):464-72. doi: 10.1158/1940-6207.CAPR-11-0315. Epub 2011 Dec 1. Cancer Prev Res (Phila). 2012. PMID: 22135045
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study.
Terhaar sive Droste JS, van Turenhout ST, Oort FA, van der Hulst RW, Steeman VA, Coblijn U, van der Eem L, Duijkers R, Bouman AA, Meijer GA, Depla AC, Scholten P, Loffeld RJ, Coupé VM, Mulder CJ. Terhaar sive Droste JS, et al. BMC Gastroenterol. 2012 Jul 24;12:94. doi: 10.1186/1471-230X-12-94. BMC Gastroenterol. 2012. PMID: 22828158 Free PMC article.
170 results